Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/17/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Gregory D. Phelps

Wrong Gregory D. Phelps?

Partner

Local Address: Boston, Massachusetts, United States
Red Sky Partners, LLC.
P.O. Box 920327
Needham, Massachusetts 02492
United States

 
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A.
    Harvard Business School
  • B.S. , electrical engineering
    Bradley University
  • MBA
    Harvard Business School
89 Total References
Web References
Board of Directors | About Us | Proteon Therapeutics
www.proteontherapeutics.com, 17 Aug 2014 [cached]
Gregory D. Phelps
Chairman of the Board; Partner, Red Sky Partners
Gregory D. Phelps has been a member of our board of directors since 2008 and has served as Chairman of the Board since 2009. Mr. Phelps is an independent advisor to biotechnology and pharmaceutical companies. He was a founder and Partner of Red Sky Partners LLC, an advisory firm providing corporate development, product strategy and leadership support to life sciences companies, from 2009 to 2014. Prior to that, Mr. Phelps served as Chairman and Chief Executive Officer of RenaMed Biologics, Inc., a private biotechnology company developing a therapeutic treatment for Acute Kidney Injury, from 2004 to 2007. His previous executive management roles include Chief Executive Officer of Ardais Corporation (2002-2003), Vice Chairman and member of the executive committee of Dyax Corporation (1998-2002), Executive Vice President and Senior Vice President of Genzyme Corporation (1991-1997), Chief Executive Officer of Viagene, Inc. (1988-1990), Chief Executive Officer of ZymoGenetics, Inc. (1986-1988) and various management positions with Baxter Travenol Laboratories, Inc., now Baxter International, Inc. (1975-1986), most recently as Vice President. Mr. Phelps' previous board directorships include Charles River School (2004-2011, board chairman 2008-2011), EPIX Pharmaceuticals Inc. (2004-2009), Ostex International Inc. (1995-2001), Atlantic Biopharmaceuticals, now Merrimack Pharmaceuticals Inc. (1998-2000), Neozyme II Corporation (1992-1996), Genzyme Transgenics Corporation, now rEVO Biologics (1993-1995) and the Hemophilia Foundation of California (1982-1984). Mr. Phelps received a B.S. in electrical engineering from Bradley University and an M.B.A. from Harvard Business School.
The board of directors is also ...
www.sec.gov, 24 April 2009 [cached]
The board of directors is also composed of (i) two class II directors (Elkan Gamzu and Gregory D. Phelps), whose term expires upon the election and qualification of directors at the annual meeting of stockholders to be held in 2010 and (ii) two class III directors (Frederick Frank and Ian F. Smith, CPA), whose terms expire upon the election and qualification of directors at the annual meeting of stockholders to be held in 2011.
...
Following the resignation of Robert J. Perez from the board of directors on February 28, 2009, the board of directors, acting pursuant to our certificate of incorporation, reclassified Gregory D. Phelps, formerly a class III director, as a class II director.
...
Gregory D. Phelps Director
...
Gregory D. Phelps(2)(3)
...
Gregory D. Phelps has served as a member of our board of directors since July 2004. Mr. Phelps is an independent management consultant and is a director of Proteon Therapeutics, Inc. Mr. Phelps was previously a director of RenaMed Biologics, Inc. from April 2007 to April 2008 and was the Chairman of the Board, President and Chief Executive Officer of RenaMed From October 2004 to April 2007. From June 2004 to
Table of Contents
September 2004, Mr. Phelps was the Vice Chairman of RenaMed. He has previously held positions of Chief Executive Officer of Ardais Corporation, Viagene, Inc. and ZymoGenetics, Inc. He has also served as Vice Chairman of Dyax Corporation, Executive Vice President of Genzyme Corporation and Vice President of Baxter Travenol Laboratories, Inc. (now Baxter Healthcare). Mr. Phelps holds a B.S. in Electrical Engineering from Bradley University and an MBA from Harvard Business School.
...
The board of directors has determined that each of Frederick Frank, Michael Gilman, Ph.D., Mark Leuchtenberger, Gregory D. Phelps and Ian F. Smith, CPA, comprising five of its six members, is an independent director within the meaning of the director independence standards of The NASDAQ Stock Market, or NASDAQ.
Epix Pharmaceuticals - Board of Directors
www.epixmed.com, 3 Aug 2006 [cached]
Gregory D. PhelpsChairman, President and CEO, RenaMed BiologicsMr. Phelps has been a member of the Board of Directors of the Company since 2004.In his twenty-eight year career in biotechnology and healthcare products, Mr. Phelps has served as Chief Executive Officer of Ardais Corporation, Viagene, Inc. and ZymoGenetics, Inc.He has also served as Vice Chairman of Dyax Corporation, Executive Vice President of Genzyme Corporation and Vice President of Baxter Travenol Laboratories, Inc (now Baxter Healthcare).Mr. Phelps has served as a member of the boards of directors of a variety of public and private biotechnology companies, and is currently on the Board of Directors of Dyax Corporation.
Investors - EPIX Pharmaceuticals: Management Biography - Epix Pharmaceuticals
investor.epixmed.com, 15 Aug 2007 [cached]
Gregory D. PhelpsChairman, President and Chief Executive Officer, RenaMed Biologics, Inc.
Mr. Phelps is the Chairman of the Board, President, and Chief Executive Officer of RenaMed Biologics, Inc., a biotechnology company developing therapeutic products.He has previously held positions of Chief Executive Officer of Ardais Corporation, Viagene, Inc. and ZymoGenetics, Inc.He has also served as Vice Chairman of Dyax Corporation, Executive Vice President of Genzyme Corporation and Vice President of Baxter Travenol Laboratories, Inc. (now Baxter Healthcare).
Investing in Dyax
www.corporate-ir.net, 3 May 2004 [cached]
Gregory D. Phelps
Gregory D. Phelps has been a director of Dyax since 1998.He was Vice Chairman and an executive officer of Dyax from 1998 to 2002.Mr. Phelps was Chief Executive Officer and a director of Ardais Corporation from 2002 to 2003.He was an executive officer of Genzyme Corporation, a biotechnology company, from 1991 to 1997, most recently as Executive Vice President.
Other People with the name "Phelps":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304